Solid Phase Extraction HLB Cartridges, 60 mg, 3 mL with DEC Caps
Past New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $25,000 to $250,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Points of contact
-
- Laquia Geathers laquia.geathers@fda.hhs.gov
- tbd@fda.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration (FDA) is forecasting a new requirement for Solid Phase Extraction HLB Cartridges, specifically 60 mg, 3 mL with DEC Caps, categorized under the Biotechnology Research and Development NAICS code 541714. The solicitation is estimated to be released on May 1, 2026, with an anticipated contract award date of July 1, 2026. This procurement appears to be for a base contract with four option years, indicating a potential multi-year commitment to these specialized laboratory extraction cartridges.
While specific award values are not disclosed, the contract opportunity includes two points of contact at the FDA: Laquia Geathers (laquia.geathers@fda.hhs.gov) and a generic email (tbd@fda.gov). The procurement is not set aside for any specific business category, suggesting it will be open to broader competitive bidding. The detailed technical specifications and exact quantity of cartridges are not provided in the forecast, which means potential vendors should be prepared to carefully review the full solicitation when it becomes available in May 2026.
Forecast text
Solid Phase Extraction HLB Cartridges, 60 mg, 3 mL with DEC Caps Base + 4 OY
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast